Betterlife Pharma Inc (BETR.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 01/31
(Values in thousands)
| 01-2025 | 01-2024 | 01-2023 | 01-2022 | 01-2021 | |
| Operating Expenses | 4,725 | 3,210 | 9,257 | 9,970 | 7,954 |
| Operating Income | -4,725 | -3,210 | -9,257 | -9,970 | -7,954 |
| Interest Expense | 319 | 51 | 67 | 58 | 40 |
| Other Income | 1,423 | 362 | -48 | -1,965 | -28,356 |
| Pre-tax Income | -3,622 | -2,899 | -9,373 | -11,993 | -36,351 |
| Income Tax | N/A | 0 | 0 | 167 | N/A |
| Net Income Continuous | -3,622 | -2,899 | -9,373 | -12,159 | -36,351 |
| Minority Interests | 102 | 9 | 357 | N/A | N/A |
| Net Income | $-3,520 | $-2,889 | $-9,016 | $-12,159 | $-36,351 |
| EPS Basic Total Ops | -0.03 | -0.03 | -0.10 | -0.16 | -1.34 |
| EPS Basic Continuous Ops | -0.03 | -0.03 | -0.10 | -0.16 | -1.34 |
| EPS Diluted Total Ops | -0.03 | -0.03 | -0.10 | -0.16 | -1.34 |
| EPS Diluted Continuous Ops | -0.03 | -0.03 | -0.10 | -0.16 | -1.34 |
| EBITDA(a) | $-3,302 | $-2,848 | $-9,287 | $-11,916 | $-35,968 |